IL1B and type 2 diabetes mellitus: Finally, crucial contribution of IL-1β to T2DM pathogenesis is demonstrated by the reduction of blood glucose levels and the improvement β-cells function in T2DM and T1DM patients treated with the interleukin-1 receptor antagonist (IL-1Ra) [49,71,72,73,74,75,76,77,78,79].